Task: Answer the multiple-choice question.
Question: Which drug exhibits a -6.515% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a Cc1ccc2sc(NC(=O)CN3C(=O)CCC3=O)nc2c1C
b Br.CN1CCN(c2nc(-c3cccs3)cs2)CC1
c O=C(COC(=O)/C=C/c1ccc(C(F)(F)F)cc1)NC1CC1
d O=C(COc1ccccc1Cl)Nc1ccccc1C(=O)N1CCCCC1
Answer: a. Cc1ccc2sc(NC(=O)CN3C(=O)CCC3=O)nc2c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc2sc(NC(=O)CN3C(=O)CCC3=O)nc2c1C
Cc1ccc2sc(NC(=O)CN3C(=O)CCC3=O)nc2c1C
N-(4,5-dimethyl-1,3-benzothiazol-2-yl)-2-(2,5-dioxopyrrolidin-1-yl)acetamide